Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

UVaDOC. Repositorio Documental de la Universidad de Valladolid
Publicación Artículo científico (JournalArticle)

Hybrid elastin-like recombinamer-fibrin gels: physical characterization and in vitro evaluation for cardiovascular tissue engineering applications

  • González de Torre, Israel
  • Weber, Miriam T.
  • Quintanilla Sierra, Luis
  • Alonso Rodrigo, Matilde
  • Jockenhoevel, Stefan
  • Rodríguez Cabello, José Carlos
  • Mela, Petra
Producción Científica, In the field of tissue engineering, the properties of the scaffolds are of crucial importance for the success of the application. Hybrid materials combine the properties of the different components that constitute them. In this study hybrid gels of Elastin-Like Recombinamer (ELR) and fibrin were prepared with a range of polymer concentrations and ELR-to-fibrin ratios. The correlation between SEM micrographs, porosities, swelling ratios and rheological properties was discussed and a poroelastic mechanism was suggested to explain the mechanical behavior of the hybrid gels. Applicability as scaffold materials for cardiovascular tissue engineering was shown by the realization of cell-laden matrixes which supported the synthesis of collagens as revealed by immunohistochemical analysis. As a proof of concept, a tissue-engineered heart valve was fabricated by injection moulding and cultivated in a bioreactor for 3 weeks under dynamic con- ditions. Tissue analysis revealed the production of collagen I and III, fundamental proteins for cardio- vascular constructs., Junta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA152A12-2, VA244U13 y VA155A12-2), Ministerio de Industria, Economía y Competitividad (proyectos MAT-2010-15982, MAT2010- 15310, PRI-PIBAR-2011-1403 y MAT2012-38043-C02-01)
UVaDOC. Repositorio Documental de la Universidad de Valladolid
Publicación Artículo científico (JournalArticle)

Control of angiogenesis and host response by modulating the cell adhesion properties of an Elastin-Like Recombinamer-based hydrogel

  • Staubli, Sebastian Manuel
  • Cerino, Giulia
  • González de Torre, Israel
  • Alonso Rodrigo, Matilde
  • Oertli, Daniel
  • Eckstein, Friedrich
  • Glatz, Katharina
  • Rodríguez Cabello, José Carlos
  • Marsano, Anna
Producción Científica, The control of the in vivo vascularization of engineered tissue substitutes is essential in order to obtain either a rapid induction or a complete inhibition of the process (e.g. in muscles and hyaline-cartilage, respectively). Among the several polymers available, Elastin-Like Recombinamers (ELR)-based hydrogel stands out as a promising material for tissue engineering thanks to its viscoelastic properties, non-toxicity, and non-immunogenicity. In this study, we hypothesized that varying the cell adhesion properties of ELR-hydrogels could modulate the high angiogenic potential of adipose tissue-derived stromal vascular fraction (SVF) cells, predominantly composed of endothelial/mural and mesenchymal cells. Human SVF cells, embedded in RGD-REDV-bioactivated or unmodified ELR-hydrogels, were implanted in rat subcutaneous pockets either immediately or upon 5-day-culture in perfusion-bioreactors. Perfusion-based culture enhanced the endothelial cell cord-like-organization and the release of pro-angiogenic factors in functionalized constructs. While in vivo vascularization and host cell infiltration within the bioactivated gels were highly enhanced, the two processes were strongly inhibited in non-functionalized SVF-based hydrogels up to 28 days. ELR-based hydrogels showed a great potential to determine the successful integration of engineered substitutes thanks to their capacity to finely control the angiogenic/inflammation process at the recipient site, even in presence of SVF cells., Ministerio de Economía, Industria y Competitividad (Project MAT-2010-15982, MAT2010- 15310, PRI-PIBAR-2011-1403 and MAT2012-38043-C02-01), Junta de Castilla y León (programa de apoyo a proyectos de investigación – Ref.VA152A12-2, VA244U13 and VA155A12-2)
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers

  • Bizeau, Joëlle
  • Tapeinos, Christos
  • Marella, Claudio
  • Larrañaga Espartero, Aitor
  • Pandit, Abhay
Atherosclerosis is a chronic inflammatory disease of the arterial wall that leads to cardiovascular diseases which are the major cause of deaths worldwide. There is currently no treatment that can stop or reverse the disease. However, the use of microparticles with anti-inflammatory properties could represent a promising treatment. Herein, spherical microparticles with a core-shell structure and an average diameter of 1 μm were synthesized. The microparticles were comprised of a MnCO3 and MnO2 core and a 4-arm PEG-amine cross-linked shell of hyaluronic acid. The HA-Mn-SM microparticles were loaded with D-α-tocopherol (vitamin-E) (TOC), to fabricate a targeted biocompatible delivery platform for the treatment of atherosclerotic inflamed cells. Loading and release studies of TOC demonstrated a lactic acid concentration dependant controlled release profile of the HA-Mn-SM mimicking the atherosclerotic environment where lactic acid is over-produced. The microparticles exhibited a high scavenging ability towards H2O2 in addition to the controlled generation of O2. The optimal results were obtained for 250 μg/mL microparticles which in the presence of 1000 μM H2O2 resulted in the scavenging of almost all the H2O2. Our results demonstrate that 50 μg/mL of microparticles scavenged continuously produced H2O2 up to a concentration of 1000 μM, a characteristic that demonstrates the sustained therapeutic effect of the HA-Mn-SM microparticles in an environment that mimics that of inflamed tissues. Our results indicate the potential use of HA-Mn-SM as a novel platform for the treatment of atherosclerosis. In vitro studies confirmed that the microparticles are not cytotoxic at concentrations up to 250 μg/mL and for 72 h. These preliminary results indicate the potential use of HA-Mn-SM as a novel drug delivery system for atherosclerotic tissues., This material is based upon works supported by the European Union funding under the 7th Framework Programme under Grant Agreement Number 317304. This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) and is co-funded under the European Regional Development Fund under Grant Number 13/RC/2073.